ARCHIVES

Phase III Five-Year Data Show Erbitux Increases Survival Of Head And Neck Cancer

This article is from The Cancer Letter archive.

Vol. 31 No. 9 | September 26, 2008

Download PDF Visit The Full Archive

Related Articles

Funding Opportunity: PanCAN Offering $4.1 Million in Research Grants

September 12, 2014

Rogers Eyes Saccharin Ban

March 18, 1977

Lasker Awards Announced

September 25, 2009

In Brief: Weicker Joins Tobacco Company Board; Hatfield To Leave Senate Next Year

December 8, 1995

In Brief: Last Two NCAB Choices Named; Hellman Heads ASCO, Sartorelli Named President Of AACR

May 16, 1986

NCCS Begins Program To Help Develop Survivors’ Care Plan

February 27, 2009